Vasculitis por adalimumab en un paciente con enfermedad de Crohn

Muñoz Villafranca, Carmen; Izu Belloso, Rosa Maria; Bravo Rodriguez, Maria Teresa; Basterra Olabarrieta, Susana.
Gastroenterol. hepatol. (Ed. impr.) ; 36(4): 296-297, abr. 2013. ilus
Artículo en Español | IBECS (España) | ID: ibc-112089

Documentos relacionados

  1. Transmural or mucosal healing in Crohn´s disease. Which is the goal to be pursued?
  2. Pyoderma gangrenosum and impact on quality of life: A narrative review.
  3. Association of Periodontal Disease with Activity of Crohn's Disease.
  4. Changes in HLA-B27 Transgenic Rat Fecal Microbiota Following Tofacitinib Treatment and Ileocecal Resection Surgery: Implications for Crohn's Disease Management.
  5. Early Combined Immunosuppression Reduces Complications in Long-standing Crohn's Disease: A Post Hoc Analysis of REACT.
  6. Microgranulomas at Diagnosis Are Associated With Need for Antitumor Necrosis Factor Escalation in Pediatric Crohn Disease.
  7. Use of teduglutide for short bowel syndrome and Crohn's disease in a patient treated with ustekinumab and vedolizumab dual biologic therapy.
  8. Can vulvar edema be the presenting sign of Crohn's disease? A case series.
  9. Renal involvement of a patient with Crohn´s disease: A case report.
  10. A Method Using Longitudinal Laboratory Data to Predict Future Intestinal Complication in Patients with Crohn's Disease.